Canntab Therapeutics Limited filed its Annual on Sep 28, 2022 for the period ending May 31, 2022. In this report its auditor, Clearhouse LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.005 CAD | -.--% | -.--% | -.--% |
Apr. 15 | Canntab Therapeutics Limited announced that it expects to receive CAD 0.1 million in funding | CI |
2023 | Canntab Therapeutics Limited Provide an Update on Product Delivery | CI |
1st Jan change | Capi. | |
---|---|---|
-.--% | 142K | |
-15.13% | 4.51B | |
-9.75% | 3.15B | |
+2.14% | 3.1B | |
-6.82% | 2.42B | |
+47.87% | 1.97B | |
+0.09% | 1.65B | |
-7.89% | 1.68B | |
-12.97% | 1.53B | |
+33.40% | 1.38B |
- Stock Market
- Equities
- PILL Stock
- News Canntab Therapeutics Limited
- Canntab Therapeutics Limited Auditor Raises 'Going Concern' Doubt